RCP Update: 11/22/23
Tracking Covid
- CDC tracker (week ending November 11)
- All indicators trending up
- +8.6% in hospital admissions
- +9.1% in percentage of COVID deaths
- CDC wastewater surveillance tracker measure of prevalence of virus
- As of November 13, 36% showed modest (10%-99%) or large (>100%) reduction in virus (915 sites reporting)
- 48% showed modest or large increase
- Contract dispute leads to indefinites shutdown of ¼ wastewater tracking sites
- Previous contractor of sites, Biobot, is appealing change to new contractor Verily
- As of November 13, 36% showed modest (10%-99%) or large (>100%) reduction in virus (915 sites reporting)
Other Threats
- Study on prevalence of pathogens among patients in Maryland acute and long-term facilities (October 26)
- 482 patient at 51 facilities
- 7% tested positive for A baumannii, 6.6% for C auris
- Significantly more common in Long Term Care Facilities
- Joint WHO and CDC report shows impact of missed measles vaccinations worldwide during pandemic
- 18% increase in cases, 43% increase estimated deaths from 2021-2022
- On track to double from 2022 to 2023
- 47 countries have reported “disruptive outbreaks” in 2023 (37 in 2022, 22 in 20921)
Guidance
- New mask mandates in health facilities in some bay area counties (November 1)
- Health Care workers (Alameda, Contra Costa, San Mateo, Sonoma)
- Health Care Workers, Patients and visitors (Santa Clara)
- CDC reports highest exemption rate ever from 4 key childhood vaccines (MMR, DTaP, polio, chickenpox) in 2022 (November 10)
- 3% rate (2.8% non-medical reasons)
- Rise in 40 states
- 10 states had raise of 5%+
- Idaho had 12%
Vaccines
RSV
- Monoclonal antibody nirsemivab (Sanofi-AstraZeneca Beyfortus) is in short supply (October 30)
- CDC Health Alert Network (HAN) Health Advisory to prioritize infants under 6 months and with underlying conditions (high risk population) (October 23)
- CDC also recommends suspending use in children 8-19 months eligible for older prophylaxis palivizumab
Covid
- Study shows vaccination of pregnant mothers gives protection to newborns up to 6 months (October 23)
- Study suggests higher prevalence of stroke risk among older adult who received flu and bivalent covid vaccine within 6 weeks of each other (October 26)m
- FDA and CMS preprint (not yet reviewed)
- Fall 2022
- 20% for Pfizer; 35% for Moderna
- Compared to those who received Covid only; no risk elevation for covid only
Mitigation
- Study suggests Paxlovid does not reduce chances of developing long covid symptoms (November 1)
- Based on analysis of records of 9,593 veterans diagnosed and treated January-July 2022
- Blood clots less frequent among Paxlovid group
- Gargling or nasal rinsing with saline associated with lower hospitalization rates for Covid (November 10)
- 55 individuals with low (27) or high (28) regimens
- Compared to 9,398 in reference population
- 2020-2022
Variants
- 10/29/23-11/11/23 distribution of subvariants (all omicron)
- 1: 29% (from EG.5)
- 5: 21.7%
- 1.5.1: 9.3%
- 3: 7.8% (also from EG.5)
- All XBB line; about 60% from EG.5 and direct descendants